Additionally, the occurrence of FGFR3 S249C mutation was less frequent in upper tract urothelial carcinoma patients compared to bladder cancer patients (37.5% vs. 59.3%) [54]. This evidence concerns the gene FGFR3 and urinary bladder cancer.